Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neo-Kidney Augment in T2DM and CKD
NCT02525263Phase 2Terminated
- Sponsor
- ProKidney
- Start
- Jul 2016
- Primary completion
- May 2017
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of rilparencel in diabetic nephropathy (DN), sponsored by ProKidney. Started Jul 2016; status: terminated.
02
Drugs
rilparencel
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02525263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02525263.